Screener/Healthcare/Biotechnology

HRTX

Heron Therapeutics, Inc.NASDAQ
$0.77-0.03 (-3.96%)
$0.75
$2.61
$0.75
$0.82
EPS (TTM)$-0.12
P/E Ratio
Dividend Yield
Market Cap$154.8M
Volume1.30M
Prev Close$0.80
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$40.6M-$3.0M$-0.0172.6%-7.3%
Q3 '25$38.2M-$17.5M$-0.1068.8%-45.8%
Q2 '25$37.2M-$2.4M$-0.0273.5%-6.4%
Q1 '25$38.9M$2.6M$0.0178.3%6.8%
Q4 '24$40.8M$3.7M$0.0274.9%9.0%
Q3 '24$32.8M-$4.8M$-0.0371.2%-14.8%
Q2 '24$36.0M-$9.2M$-0.0670.8%-25.6%
Q1 '24$34.7M-$3.2M$-0.0275.6%-9.1%
Get Your Daily Market Recap